Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fructose SCHEMBL159418 | 1.00 | CYP2C9 (0.56) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL7707744 | 1.00 | CYP2C9 (0.56) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL1576054 | 1.00 | CYP2C9 (0.56) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL19744235 | 1.00 | CYP2C9 (0.56) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Tagatose SCHEMBL7524214 | 1.00 | CYP2C9 (0.56) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL27523433 | 1.00 | CYP2C9 (0.56) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL80090 | 1.00 | CYP2C9 (0.56) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL8469522 | 0.98 | CYP2C9 (0.54) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Fructose SCHEMBL751281 | 0.98 | CYP2C9 (0.54) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Tagatose SCHEMBL23827342 | 0.97 | CYP2C9 (0.58) | CYP2C9TSHRPDE4ALMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0379147-B1 | Extrudable elastic gel for use as carrier for therapeutic agent | STERLING WINTHROP INC (US) | 1994-09-28 | — | — | EP | claimed |
| EP-2828265-A1 | ISOLATION OF ANHYDRO SUGAR ALCOHOLS BY SELECTIVE ADSORBENTS | BIOeCON International Holding N.V. (AN) | 2015-01-28 | — | — | EP | disclosed |
| US-20140323746-A1 | ISOLATION OF ANHYDRO SUGAR ALCOHOLS BY SELECTIVE ADSORBENTS | BIOECON INT HOLDING NV (NL) | 2014-10-30 | — | — | US | disclosed |
| WO-2013107735-A1 | ISOLATION OF ANHYDRO SUGAR ALCOHOLS BY SELECTIVE ADSORBENTS | BIOECON INTERNATIONAL HOLDING N.V. (CW) | 2013-07-25 | — | — | WO | disclosed |
| EP-2615093-A1 | Isolation of anhydro sugar hexitols by selective adsorbents | BIOeCON International Holding N.V. (AN) | 2013-07-17 | — | — | EP | disclosed |
| WO-2002055184-A1 | EMULSIFIERS FOR EXPLOSIVE COMPOSITIONS | MEGACHEM PTY LTD (AU) | 2002-07-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140323746-A1 | ISOLATION OF ANHYDRO SUGAR ALCOHOLS BY SELECTIVE ADSORBENTS | ALDOA, ADH1C, DERA | CYP2C9 3528/4885TSHR 738/4885PDE4A 3993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.